Sponsor Pipeline

Philip Kern Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
2
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-19 NCT07605091
RELIANCE: Moringa in Lactation and Early Childhood		 Primary endpoint(s) modified
Active Trials by Phase
Phase 4
1
Phase 2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT05051436 The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics Pre-diabetes Recruiting
Phase 2
NCT04666636 Mechanisms for Activation of Beige Adipose Tissue in Humans PreDiabetes Recruiting
Not specified
NCT07605091 RELIANCE: Moringa in Lactation and Early Childhood Breast Feeding Not Yet Recruiting
Disease Areas
Diabetes (2) Obesity (1)
Get alerts when Philip Kern's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free